STTCOMP PAA FA Long
Soi 387 mil
Mkt cap $147 mil
Last traded 38 cents
PAA ia biotech company conducting trials for treatment of MND Motor Nueron Disease
Released results of phase 2 trials after market today.
I sold out of PAA Friday but todays results are great. No safety issues and the bottom line is
Using the prognostic predictor model described in Elamin et al., 2015, 1 depending on the current severity of the disease, a 0.48 slope change as calculated for all 12 patients could provide patients with an additional 13.5- 56.5 months in median survival. Currently approved treatments for ALS/MND provide approximately 2 – 9 months in
additional life expectancy.
So PAA kick life expectancy 5 times longer than the current $1 b companies treatment.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 26 Feb
Short Term Trading Week Starting: 26 Feb, page-23
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated